Wednesday, 7 September 2016

Retrophin's kidney drug succeeds in mid-stage study

(Reuters) - Retrophin Inc said its rare kidney disorder drug met the main goal of a mid-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)